RPX Corp. Director Randy Komisar Sells 10,354 Shares (RPXC)
RPX Corp. (NASDAQ:RPXC) Director Randy Komisar sold 10,354 shares of the stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $15.20, for a total transaction of $157,380.80. Following the transaction, the director now directly owns 9,498 shares of the company’s stock, valued at approximately $144,370. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
RPX Corp. (NASDAQ:RPXC) traded down 0.99% during mid-day trading on Wednesday, hitting $15.05. 133,075 shares of the company’s stock traded hands. RPX Corp. has a 52 week low of $14.55 and a 52 week high of $18.75. The stock has a 50-day moving average of $15.86 and a 200-day moving average of $16.33. The company has a market cap of $808.5 million and a price-to-earnings ratio of 24.05.
RPX Corp. (NASDAQ:RPXC) last announced its earnings results on Tuesday, July 29th. The company reported $0.24 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.22 by $0.02. The company had revenue of $64.30 million for the quarter, compared to the consensus estimate of $63.72 million. During the same quarter in the prior year, the company posted $0.26 earnings per share. The company’s quarterly revenue was up 16.9% on a year-over-year basis. On average, analysts predict that RPX Corp. will post $0.97 earnings per share for the current fiscal year.
A number of analysts have recently weighed in on RPXC shares. Analysts at Barclays downgraded shares of RPX Corp. from an “overweight” rating to an “equal weight” rating in a research note on Monday, August 4th. They now have a $17.00 price target on the stock, down previously from $20.00. Analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of RPX Corp. in a research note on Monday, July 21st. They now have a $19.00 price target on the stock, up previously from $18.50.
RPX Corporation (NASDAQ:RPXC) provides patent risk management solutions, offering defensive buying, acquisition syndication, patent intelligence and advisory services.
Receive News & Ratings for RPX Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RPX Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.